Investment set to Spur Oral Medicines Growth
CDMO and full service provider Hermes Pharma is investing a further €25 million in its manufacturing capabilities, arming the company with new equipment, increased production and storage capacity, as well as greater operational efficiency to meet the rapidly growing market demand for user-friendly oral dosage forms. Click to read more...